Pediatric pseudo-Meigs' syndrome secondary to a Sertoli-Leydig cell tumor with elevated cancer antigen 125 and alpha-fetoprotein: A case report

儿童假性梅格斯综合征继发于支持细胞-间质细胞瘤伴癌抗原125和甲胎蛋白升高:病例报告

阅读:1

Abstract

INTRODUCTION: Pseudo-Meigs' syndrome is described as the triad of a pleural effusion, ascites, and pelvic or abdominal tumor that is not an ovarian fibroma or thecoma. To our knowledge, this is the first reported pediatric case of pseudo-Meigs' syndrome secondary to a Sertoli-Leydig cell tumor (SLCT). PRESENTATION OF CASE: A 12-year-old female with a past medical history of asthma and obesity (body mass index of 37) presented to the emergency department with complaints of abdominal pain, loss of appetite, irregular menses, and shortness of breath for one month. An abdominal ultrasound was obtained which showed a very large echoic heterogeneous structure involving the entire abdomen and moderate perihepatic and pelvic ascites. Computed Tomography (CT) imaging showed a large right pleural effusion with collapse of the right lower lobe, partial collapse of the right middle and upper lobes, and a 21.6 × 21.3 × 14.6 cm complex cystic mass in the abdomen. Tumor markers were significant for an elevated Cancer Antigen-125 (CA-125) of 1227 U/mL and alpha-fetoprotein (AFP) of 2385 ng/mL. She subsequently underwent right pleural thoracentesis, right tube thoracostomy, exploratory-laparotomy, and left salpingo-oophorectomy. Surgical pathology was consistent with a poorly differentiated SLCT. DISCUSSION: SLCT are rare sex cord-stromal ovarian tumors that produce testosterone and account for less than 0.5 % of ovarian tumors. They are a rare cause of Psuedo-Meigs' syndrome. CONCLUSION: Pseudo-Meigs' syndrome secondary to a SLCT in an adolescent is an exceedingly rare diagnosis. Multidisciplinary care for these patients consisting of pediatric surgery, general pediatrics, and pediatric hematology/oncology services is critical for management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。